


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Recently Viewed
ALT
Altimmune
WSO
Watsco
PPTA
Perpetua Resources C
ABCL
AbCellera Biologics
BNTX
BioNTech
Most Trending
+22.23%
+10.11%
+2.46%
ALT
Altimmune
$4.76
Strengths

Upgraded on attractively valued

Outperform the market
ALT Price Performance
$4.05 (+17.53%)
$3.56 (+33.71%)
$4.74 (+0.42%)
$8.74 (-45.54%)
ALT has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

ALT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Outperform the market
![]()
ALT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
ALT Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is ALT current stock price?
What are ALT stock strengths?
What is ALT Risk Level?
What is ALT market cap and volume?
What is ALT current Stock IQ?
Should I buy ALT stock right now?
Is ALT a Strong Buy right now?
What does a 'Strong Buy' rating mean for ALT?
What does a 'Strong Sell' rating mean for ALT?
What factors influence ALT's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Recently Viewed
ALT
Altimmune
WSO
Watsco
PPTA
Perpetua Resources C
ABCL
AbCellera Biologics
BNTX
BioNTech
Most Trending
+22.23%
+10.11%
+2.46%
ALT
Altimmune
Current Price
$4.76
Stock Insights
Strengths

Upgraded on attractively valued

Outperform the market

ALT Price Performance
$4.05 (+17.53%)
$3.56 (+33.71%)
$4.74 (+0.42%)
$8.74 (-45.54%)
ALT Analysts Opinion
ALT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Outperform the market
![]()
ALT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
ALT Street Sentiment is extremely bullish and have positive views on the near-term outlook
ALT has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

Average key support and resistance price levels
ALT Stock IQ
ALT Latest Analysis
Altimmune CEO Vipin Garg To Step Down. Stock Down In Pre-Market . (RTTNews) - Altimmune Inc.(ALT) a developer of novel peptide-based therapeutics for liver and metabolic diseases said on Monday that its Chief Executive Officer Vipin Garg will step down with effect from January 1 2026.
Mon Dec 1, 2025
Wall Street Analysts Predict a 250.59% Upside in Altimmune (ALT): Heres What You Should Know. The average of price targets set by Wall Street analysts indicates a potential upside of 250.6% in Altimmune (ALT). While the effectiveness of this highly sought-after metric is questionable the positive trend in earnings estimate revisions might translate into an upside in the stock.
Tue Nov 25, 2025
Altimmune Inc. (ALT) Presents at Jefferies London Healthcare Conference 2025 Transcript.
Thu Nov 20, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.